March 4, 2024

Today, the U.S. Food and Drug Administration (FDA) updated its list of select chemicals currently under the agency’s review to provide more insight on the status of the FDA’s post-market assessments of chemicals in the food supply. The agency first published a list in July 2023.

This updated list includes select food ingredients (including food and color additives), food contact substances, and contaminants under FDA review. The list now includes information about the status of our post-market assessments, including where we are in the risk assessment and management process. The list also provides links to public information about our post-market actions. The FDA anticipates updating this list regularly.

While these post-market assessments take time, one of the key reasons for the proposed Human Foods Program transformation is to enhance our review of food chemical safety. The proposed Human Foods Program would include the Office of Food Chemical Safety, Dietary Supplements and Innovation where we intend to develop a systematic and more nimble process for evaluating chemicals in the food supply. The FDA’s assessment of chemicals in the food supply is part of our commitment to food safety.

For More Information

List of Select Chemicals in the Food Supply Under FDA Review
Food Chemical Safety
Conversations with Experts: FDA Works to Enhance the Assessment of Ingredients in Foods and Food Contact Substances on the Market
FDA Voices Blog: How FDA’s New Approach to Reviewing Chemicals Added to Food Will Strengthen Food Safety

 

Contact us
Thank you for your interest in Garg Law PLLC.
Our commitment to understanding your regulatory questions and business goals, and helping you achieve results starts here.
If you are looking for representation on a new matter, please fill out the form below to request a free consultation. The form enables us to conduct a preliminary check for potential conflicts of interest and to determine if we can proceed with the free consultation.
Garg Law Global Icon

News & Insights

Get the latest news on FDA regulatory delivered straight to your inbox.